 Caladrius Biosciences, Inc. NASDAQ:CLBS Q2 2022 Results Conference Call August 4, 2022 4:30 PM ET Company Participants John Menditto - VP, IR Corporate Communications David Mazzo - President, CEO Kristen Buck - EVP, Research and Development CMO James Nisco - VP, Finance Treasury Conference Call Participants Kumar Raja - Brookline Capital Pete Enderlin - MAZ Partners Operator Welcome to the Caladrius Biosciences Second Quarter 2022 Financial Results and Business Update Conference Call. Currently all participants are in listen-only mode. 